Kalvista Pharmaceuticals
KALV
Insidertransaktionen und Aktienkurs 2022-2024
23.8.2024
| Verkauf | Yea, Christopher |
CHIEF DEVELOPMENT OFFICER
|
12,4 $
|
23.758 $
|
23.8.2024
| Verkauf | Audhya, Paul K. |
CHIEF MEDICAL OFFICER
|
12,4 $
|
26.474 $
|
19.8.2024
| Verkauf | Yea, Christopher |
CHIEF DEVELOPMENT OFFICER
|
12,0 $
|
85.318 $
|
19.8.2024
| Verkauf | Palleiko, Benjamin L. |
CHIEF EXECUTIVE OFFICER
|
12,0 $
|
170.769 $
|
19.8.2024
| Verkauf | Audhya, Paul K. |
CHIEF MEDICAL OFFICER
|
12,0 $
|
95.782 $
|
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung!
© U.S. Securities and Exchange Commission (SEC)